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Background:Dietary inadequacy and adiposity, both prevalent in the chronic spinal cord injury (SCI) population,
are known to inﬂuence bone turnover and may be potential modiﬁable risk factors for the development of
sublesional osteoporosis following SCI. This pilot study in an SCI cohort aimed to assess measures of nutrition
and obesity, to determine if these measures were associated with bone mineral density (BMD), and to compare
these measures to a non-SCI control cohort.
Methods: In a cross-sectional observational study, volunteers with chronic SCI (N1 year post-injury, lesions from
C1 to T12 and severity category A–D by the American Spinal Injury Association Impairment Scale)were assessed,
and 8 non-SCI individualswere recruited as a comparison group. BMD at the femoral neck (FN) and lumbar spine
(LS), and an estimate of visceral adipose tissue (VAT) from lumbar vertebrae 1 through 4 were measured using
dual energy X-ray absorptiometry (DXA); nutrient intake of calcium, vitamins D & K, and proteinwere estimated
using a food frequency questionnaire; plasma 25-hydroxyvitamin D (25(OH)D) was analyzed using ultra-high
performance liquid chromatography/tandem mass spectroscopy; and serum leptin, adiponectin and insulin
were analyzed using a multiplex assay.
Results: A total of 34 individuals with SCI (n = 22 tetraplegic; n = 12 paraplegic; 94% male) who averaged 12.7
(9.0) years post-injury, age 40.0 (10.9) years and% body fat of 28.4 (7.3)were assessed.Multiple linear regression
analyses in the SCI cohort showed signiﬁcant associations between BMD at the FN and LS with leptin (FN: r =
0.529, p = 0.005; LS: r = 0.392, p = 0.05), insulin (FN: r = 0.544, p = 0.003; LS: r = 0.388, p = 0.05), and
VAT percent (FN: r = 0.444, p = 0.02; LS: r = 0.381, p = 0.05). Adiponectin was only correlated with LS BMD
(r = 0.429, p = 0.03). No signiﬁcant relationships were found between BMD and serum 25(OH)D, or intakes
of calcium, vitamins D & K, and protein. Intake of vitamin D was adequate in 69% of participants with SCI,
where 91% of those persons consumed either vitamin D and/or multivitamin supplements. Vitamin D status
was similar between SCI and non-SCI groups aswas sub-optimal status (25(OH)D b 75 nmol/L) (60% of SCI com-
pared to 50% of non-SCI). Participants with SCI had signiﬁcantly lower FNBMD in comparison to non-SCI controls
(p = 0.001).
Conclusions: Compromised BMD among individuals with SCI was not associatedwith a deﬁciency of vitamin D or
other bone nutrients. The observed positive associations between BMD and leptin, insulin, adiponectin and VAT
provide a framework to evaluate links between adiposity and bone health in a larger SCI cohort.© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Impairment Scale; DRI, dietary
, foodfrequencyquestionnaire;
ublesional osteoporosis; UPLC/
ndemmass spectrometry; VAT,
s 3A44, McMaster University,
. This is an open access article under1. Introduction
Sublesional osteoporosis (SLOP) is a disease speciﬁc to the spinal
cord injury (SCI) population associated with excess bone resorption
paired with reduced bone formation below the level of lesion (Craven
et al., 2009). The dramatic loss of bonemineral density (BMD) increases
the risk of acquiring fragility fractures at the distal femur, proximal tibia,
and hip regions (Craven et al., 2009). There is a preservation of BMD at
the lumbar spine (LS) during the chronic phase of SCI, which may be
due to the maintenance of load on the spine while sitting in athe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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composition of the LS with high bone turnover can cause changes in
BMDprior to fracture (Craven et al., 2009) andmanyvertebral compres-
sion fractures at this site go undetected in other clinical disorders such
as steroid drug-induced bone loss (Rodd et al., 2012a). The occurrence
of SLOP is estimated to be up to 82% in individuals with SCI (Craven
et al., 2009). Although nutrition and adiposity have known roles in the
regulation of bone metabolism, the importance of these factors com-
pared to loss of weight bearing in those with SCI is not well deﬁned.
Sub-optimal vitamin D status is common in the SCI population
(Hummel et al., 2012; Bauman et al., 1995, 2005; Oleson et al., 2010;
Nemunaitis et al., 2010). It is attributed to limited exposure to sunlight
due to reduced mobility, use of medications that accelerate vitamin D
metabolism, and/or low vitamin D intake due to calcium-restricted
diets during acute care to avoid hypercalciuria (Bauman et al., 1995). In-
take of calcium may thus also be compromised. Whether persons with
greater fracture risk, such as the SCI population, require nutrient intakes
higher than the dietary reference intakes suggested for the average pop-
ulation is unknown (Hanley et al., 2010; WHO Scientiﬁc Group, 2003).
Other factors that may inﬂuence bone formation and resorption in
personswith SCI include pro-inﬂammatory cytokines released from ex-
cess adipose tissue (Cao, 2011). Leptin has been suggested to regulate
bonemetabolism primarily through the peripheral pathway promoting
bone formation (Turner et al., 2013; Khosla, 2002). Leptin receptors on
osteoblasts increase osteoblast differentiation while decreasing adipo-
cyte differentiation, as they are both derived from a common multi-
potential mesenchymal stem cell lineage (Thomas, 2003). Excess
adiposity also increases exogenous insulin, which binds to insulin
receptors on osteoblast cells and directly induces osteoblast activity
(Karsenty and Ferron, 2012). Similarly, adiponectinmay be a biomarker
for bone loss and fracture risk as it is inversely related to BMD and
central adiposity (Liu et al., 2013). Alternative theories regarding the
fat–bone relationship suggest thatmechanical loadingby fat andmuscle
mass on bone tissue is associated with increased osteoblast activity,
strengthening bones in regions of high stress (Jiang et al., 2006). In
persons with SCI, body weight percentage as adipose tissue mass can
be 8–18% higher than in age-, height-, and/or weight-matched non-SCI
controls (Buchholz and Bugaresti, 2005). Following SCI, adipose tissue
accumulation in parallel with loss of muscle and bone tissue indicates a
disruption in adipose-associated bone metabolism (Jiang et al., 2006).
The presence of SLOP (Craven et al., 2009), nutrient inadequacy
(Walters et al., 2009), and obesity (Rajan et al., 2008) in the SCI popula-
tion suggests that a unique cross-regulation may exist. Characterizing re-
lationships between markers of these physiologic states will further our
understanding of bone health in the SCI population and may help in the
detection and treatment of SLOP. This pilot study sought to assess bone-
related measures of nutrition and obesity in a SCI cohort and determine
if these measures are associated with BMD at the femoral neck (FN) and
LS. Secondary goals were to identify correlates of suboptimal vitamin D
status (e.g. winter assessment, vitamin D intake), and compare measure-
ment outcomes to a small representative sample of non-SCI individuals.
2. Methods
2.1. Study setting and population
The study was conducted at McMaster University in Hamilton,
Ontario, Canada; data were collected between March 2011 and April
2013. The Hamilton Integrated Health Sciences Research Ethics Board ap-
proved the study protocol and consentwas obtained fromeach volunteer.
Individuals enrolled in the study were at least 12 months post-SCI
(traumatic or non-traumatic) ranging in impairment from C1 to T12,
and ranging in severity fromA to D as categorized by the American Spinal
Injury Association Impairment Scale (AIS) (Kirshblum et al., 2011). The
non-SCI individuals serving as a comparison group were matched for
sex, age, waist circumference (WC), and body mass index (BMI).2.2. Outcome measures
2.2.1. Medical history and demographics
Demographics, injury characteristics, and medical history were
obtained by interview. Body mass was measured using a digital wheel-
chair scale (Detecto BRW-1000 Digital Bariatric Wheelchair Scale,
DETECTO, Webb City, MO, USA) to the nearest 0.1 kg and body length
was measured on the right side of the body while lying supine to the
nearest 0.1 cm. WC was taken in the supine position after normal expi-
ration immediately below the lowest rib with the same tapemeasure as
used for participant length (Gulick II) (Edwards et al., 2008). For each
WC measurement, the tape measure was placed directly on the skin
with the participants' arms by their sides. Each measurement was
taken to the nearest 0.1 cm.2.2.2. Body composition
Dual energy X-ray absorptiometry (DXA) scans were performed
using Hologic QDR-4500A (Hologic Inc., Waltham, MA, USA). Scan
acquisition and analyses were completed following the manufacturers'
guidelines for assessing areal BMD (aBMD) at the LS (lumbar vertebrae
1–4 or a minimum of two consecutive vertebrae) and FN of the left hip
(Rajan et al., 2008); body fat and visceral adipose tissue (VAT)were an-
alyzed from a whole body scan, where a demarcated region of interest
from lumbar vertebrae 1 through 4 quantiﬁed VAT (Glickman et al.,
2004). Quality control tests were performed daily using a phantom,
and measurements were maintained within the manufacturer's
standards of b1%. Both T and Z-scores were calculated using a reference
database for non-SCI individuals provided by the Hologic software;
T-scores were used for participants over 50 years and Z-scores were
used for participants under 50 years (Schousboe et al., 2013).2.2.3. Food and supplemental nutrient intake
Average daily dietary intakes of calcium, vitamins D and K, and
protein were assessed using a previously validated food frequency
questionnaire (FFQ) (Pritchard et al., 2010). Supplement use of mul-
tivitamins, calcium, and vitamin D were documented regarding
amount(s) and duration of use. Dietary nutrient intake refers to the
consumption of the nutrient from food, whereas absolute nutrient
intake refers to the consumption of food plus supplements. To assess
the adequacy of nutrient intake, reported intakes were compared to
the estimated average requirement (EAR) for vitamin D (400 IU/day),
calcium (800 mg/day) and protein (0.66 g/kg/day) and the adequate
intake of vitamin K (120 μg/day) for adults aged over 18 years as recom-
mended by Health Canada (Institute of Medicine, 2001, 2011, 2002).2.2.4. Blood collection and analyses
Blood samples collected following a 12-hour fast were spun and
frozen at−80 °C. Plasma 25(OH)D was quantiﬁed in triplicate using
ultra high performance liquid chromatography tandemmass spectrom-
etry (UPLC/MS–MS). The protocol for sample preparation was based on
the Waters Alliance and Hymoller and Jensen protocol for HPLC LC/
MS–MS with minor modiﬁcations (Hymoller and Jensen, 2011; Calton
et al., 2008). The coefﬁcient of variation (CV) for low and high
25(OH)D quality control measurements run ﬁve times was b10%.
Although there is no universal deﬁnition for optimal 25(OH)D status
for bone health, the Institute of Medicine (IOM) deﬁnes adequacy as
N50 nmol/L (Institute of Medicine, 2011). We deﬁned sub-optimal
vitamin D status as b75 nmol/L as recommended by the International
Symposium on the Nutrition Aspects of Osteoporosis for persons with
increased risk of fracture (Dawson-Hughes et al., 2005). Serum samples
were analyzed for leptin, insulin, and adiponectin using the Milliplex®
Map Kit for Human Adipokine Magnetic Bead Panel 2 (Millipore
Corporation, Billerica, CA) in duplicate.
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Descriptive statistics were computed by calculating the mean (SD)
and count (percent) for categorical variables. The primary objective was
explored using multiple linear regression analyses to associate BMD (LS
and FN)with calcium intake, 25(OH)D status, leptin, insulin, adiponectin,
and VAT. To address the secondary objective of characterizing vitamin D
status among those with SCI, the sample was dichotomized based on op-
timal (≥75 nmol/L) and suboptimal (b75 nmol/L) 25(OH)D. Univariate
logistic regression analyses were then performed to identify whether
the following characteristics were associated with suboptimal vitamin D
status: winter assessment, inadequate absolute vitamin D intake (as
deﬁned by EAR), no vitamin D supplement use, no multivitamin supple-
ment use, and medications affecting vitamin D metabolism. Seasonal
variation of 25(OH)D was deﬁned by samples collected in winter
(November to April) or summer (May to October) months. Odd ratios
(ORs), 95% conﬁdence intervals (CI) and p-values were reported. Inde-
pendent sample t-tests were performed between the whole SCI group
(n = 34) and the SCI (n = 8) to ensure that our matched sample was
representative of our cohort and between SCI (n = 8) and the matched
non-SCI comparison group (n=8), where p-value b0.05was considered
signiﬁcant. Statistical analyses were performed using the Statistical
Program for Social Sciences (SPSS) (version 19.0; SPSS Inc., Chicago, IL).3. Results
3.1. Recruitment and sample size
A total of 34 SCI and 8 non-SCI participants were recruited to partic-
ipate in the study, with a complete data set for 27 SCI and 8 non-SCI
participants. Reasons for missing data included: metal interference
with DXA, patient's weight exceeded the maximum capability of the
DXA machine, loss of communication, and one participant declining
blood draw.3.2. Participant characteristics
Participant and injury characteristics of the cohort consisting of 34
wheelchair-bound Caucasian participants with chronic SCI are summa-
rized in Table 1. Neurological lesions varied from C1 to T11 and severity
category from A to D (A= 13, B = 4, C = 16, D = 1) by AIS. Sixty-two
percent of the male participants with SCI were obese when considering
their body fat percent (N25%), and 100% of the female SCI participants
were obese (N32%) (WHO Consultation, 2000). The 8 male non-SCI
participants who were sex, age, WC- and BMI-matched to 8 of the
participants with paraplegia had a mean age of 42.5 (6.7) years, BMI
of 25.8 (3.8) kg/m2, WC of 91.9 (9.48) cm and 20.70% body fat.Table 1
Participant and injury characteristics of SCI cohort. Values are mean (SD).* n = 29
Subject characteristics (n = 34)
Male/female (n) 32/2
Age (years) 40.0 (10.9)
Height (m) 1.75 (0.08)
Mass (kg) 82.1 (16.6)
BMI (kg/m2) 26.5 (4.7)
WC (cm) 93.0 (13.6)
Body fat (%)* 28.4 (7.3)
Injury characteristics # Participants
Motor complete/Incomplete (n) 17/17
Tetraplegia/Paraplegia (n) 22/12
Traumatic/Non-traumatic (n) 27/7
Time post injury (years) 12.7 (9.9)3.3. Outcome measures
3.3.1. Bone mineral density and visceral adipose tissue
BMD and VAT outcomes are summarized in Table 2. Based on the FN
T and Z-scores, 32% of participants with SCI had lower than expected
Z-scores for age and sex (≤−2), 11% were at an increased risk of frac-
ture with low bone mass (T-score−1 to−2.5), 4% were at high risk of
fracture and would be diagnosed with osteoporosis (T-score ≤ −2.5)
(Schousboe et al., 2013). SCI compared to non-SCI participants had a sig-
niﬁcantly lower FN BMD (p = 0.001) (Table 2). All other measurement
outcomes were not signiﬁcantly different between SCI and non-SCI.
3.3.2. Dietary and supplemental nutrient intake
Intakes of vitaminD, calcium, vitamin K, and protein are summarized
in Table 2. Vitamin D supplements were consumed by 63% of the SCI co-
hort in amounts ranging from 500 to 2000 IU per day, with one individ-
ual reporting taking 50,000 IU weekly at the time of assessment; 50% of
participants were consuming at least 1000 IU per day not including a
multivitamin. SCI compared to non-SCI participants had a signiﬁcantly
higher vitamin D intake Table 2. Calcium supplements of 300 to
2200mg/day were consumed by 41% of participants with SCI andmulti-
vitamins containing between 400 and 800 IU of vitamin D and between
200 and 500 mg of calcium by 69% of participants. Without taking into
account supplement intake (i.e. obtained from food only), 13% of the co-
hort fell below the EAR for calcium and 84% for vitamin D. Mean vitamin
K and protein intakes were similar across SCI and non-SCI groups and
exceeded the adequate intake of vitamin K (90–120 μg/day) and EAR
of protein (0.66 g/kg/day) for females andmales over 18 years (Table 2).
3.3.3. Vitamin D status
Suboptimal plasma 25(OH)D status (b75 nmol/L) was observed in
60% of the SCI cohort, of which 10% were truly deﬁcient (b30 nmol/L).
Mean (SD) plasma 25(OH)D in the optimal category was 92.3 (12.0)
nmol/L (n = 13) while in the suboptimal category was 54.4 (14.9)
nmol/L (n = 20) for participants with SCI. Univariate logistic regression
analyses revealed that participants with SCI not taking multivitamin
supplements had increased odds of having suboptimal vitamin D status
(OR = 0.171, CI = 0.033–0.893, p = 0.036). The mean 25(OH)D values
for individuals with SCI consuming multivitamin supplements was 86.9
(21.2) nmol/L (n = 10) and for those without supplements was 63.1
(20.4) nmol/L (n=23). No other potential correlates of deﬁcient vitamin
D statuswere signiﬁcant in the SCI cohort. The vitaminD status of the SCI
and non-SCI comparison groups was not signiﬁcantly different, and 50%
of the non-SCI group had suboptimal plasma 25(OH)D status (Table 2).
3.3.4. Bone and adiposity measures
In participants with SCI, BMD at the FN and LS was signiﬁcantly asso-
ciated with leptin, insulin and VAT%, as was LS BMD with adiponectin
(Table 3). An example of the signiﬁcant positive, moderate correlation
found between FN BMD and VAT is presented in Fig. 1. None of the
other outcomemeasureswere signiﬁcantly related to BMDat the FNor LS.
4. Discussion
In our study cohort of 34 adults with chronic SCI, BMD at the FN and
LS were associated with circulating adipokines and VAT, but not with
any measure of nutrition. Sub-optimal bone status at the FN was
signiﬁcantly greater in participants with SCI than in a matched healthy
reference group of non-SCI persons.
The positive associations found between BMD and VAT, leptin,
insulin and adiponectin in the present study can be attributed to several
potential mechanisms (Qin et al., 2010). It is postulated that higher
body weight increases mechanical loading on bones, activating osteo-
blast cells for bone formation (Qin et al., 2010). Alternatively, metabolic
factorsmay have an impact on BMD; greater adipose tissue is associated
with higher secretion of bone-active hormones such as leptin and
Table 2
Outcome measures for participants with spinal cord injury (SCI) for whole group and for SCI compared to matched non-SCI comparison group.
SCI SCI vs non-SCI p-Value
Bone mineral density
Femoral neck BMD (g/cm2) N 28 7 8
Mean (SD) 0.69 (0.19) 0.63 (0.16) 0.92 (0.12) 0.001
T-score −1.04 (n = 5) −2.50 (n = 1) −0.9 (n = 2) N/A
Z-score −1.49 (n = 23) −1.70 (n = 6) 0.68 (n = 6) N/A
Lumbar spine BMD (g/cm2) N 27 8 8
Mean (SD) 1.12 (0.17) 1.12 (0.2) 1.08 (0.10) 0.630
T-score 0.37 (n = 6) 0.15 (n = 2) −0.4 (n = 2) N/A
Z-score 0.29 (n = 21) 0.25 (n = 6) 0.07 (n = 6) 0.837
Visceral adipose tissue (kg) N 29 8 8
Mean (SD) 3.11 (1.47) 2.75 (1.42) 2.29 (1.44) 0.533
VAT (%) 29.1 (8.73) 26.7 (8.69) 22.0 (8.8) 0.298
Total nutrient intake N 32 8 8
Vitamin D (IU/day) Mean (SD) 1224 (1315) 1321 (696) 396 (288) 0.007
Range 155–7413 250–2246 4–907
% below EAR 31.3 25.0 62.5 0.149
Calcium (mg/day) Mean (SD) 1611 (787) 1765 (679) 1613 (907) 0.712
Range 63–3646 1014–2440 236–3117
% below EAR 9.4 0 25.0 0.149
Vitamin K (μg/day) Mean (SD) 193 (212) 172 (175) 254 (289) 0.505
Range 15–1181 17–528 66–934
Protein (g/day) Mean (SD) 82 (36) 90 (29) 93 (39) 0.859
Range 23–186 51–139 12–144
% below EAR 25.0 12.5 12.5 1.000
Blood biomarkers N 33 8 8
25 (OH)D (nmol/L) Mean (SD) 69.3 (23.3) 89.9 (14.3) 76.5 (19.8) 0.144
Range 18–120 69–104 50–115
Leptin (ng/mL) Mean (SD) 14.8 (31.4) 5.1 (3.3) 5.7 (5.2) 0.770
Range 0.21–180 0.21–10.6 1–16
Insulin (pg/L) Mean (SD) 288 (234) 204 (89) 236 (116) 0.543
Range 58–1180 90–320 111–437
Adiponectin (ng/mL) Mean (SD) 40.5 (44.0) 24.9 (23.3) 18.7 (10.5) 0.505
Range 8-200 11–81 7.2–39.9
Values aremean (SD). BMD T-scorewas calculated in participants N50 years; Z-scorewas calculated in participants b50 years. p-Value represents independent t-test betweenmatched SCI
and non-SCI groups.
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2010). Since the subpopulation of individuals with SCI experience a
lack of mechanical loading below the level of lesion, metabolic inﬂu-
ences from systemic hormone regulation are likely major contributors
to BMD regulation.
Associations between adiposity measures and BMDwere previously
reported in a chronic SCI cohort (Doherty et al., 2014; Bauman et al.,
2006); our data support and extend the proposal that adipokines may
be candidate biomarkers for BMD in SCI-related sublesional osteoporo-
sis. A previous study reported an inverse relationship betweenTable 3
Multiple linear regression analyses for measurements in participants with SCI (n = 25-27).
Variables Unstandardized
coefﬁcients
r P-value 95.0% CI
B Std. Error
BMD FN
Calcium intake 0.000 0.000 0.115 0.561 0.00–0.00
25(OH)D −0.002 0.002 − .221 0.268 0.00–0.00
Leptin 0.010 0.003 .529 0.005⁎ 0.00–0.02
Insulin 0.000 0.000 .544 0.003⁎ 0.00–0.00
Adiponectin 0.000 0.001 .227 0.255 0.00–0.00
VAT % 0.010 0.004 .444 0.018⁎ 0.00–0.02
BMD LS
Calcium intake 0.000 0.000 .026 0.899 0.00–0.00
25(OH)D 0.000 0.001 .009 0.996 0.00–0.00
Leptin 0.007 0.003 .392 0.048⁎ 0.00–0.01
Insulin 0.000 0.000 .388 0.050⁎ 0.00–0.00
Adiponectin 0.002 0.001 .429 0.029⁎ 0.00–0.00
VAT % 0.008 0.004 .381 0.048⁎ 0.00–0.02
⁎ P-value b 0.05.circulating adiponectin and SLOP in SCI wheelchair users rather than
walkers, but the site of BMD measure was not indicated (Doherty
et al., 2014). These ﬁndings suggest that osteoprotective beneﬁts of obe-
sity require mechanical loading in order to mitigate the resorptive ef-
fects of adiponectin (Karsenty and Ferron, 2012). Another study
compared individuals with SCI to their non-SCI monozygotic twin, and
reported signiﬁcant positive relationships between leg BMD or BMC
with total body fat percent, leg fat mass and serum estradiol in the SCI
group, where only leg lean mass was correlated to leg BMD or BMC
among the non-SCI twins (Bauman et al., 2006). The markers of0.0 0.5 1.0 1.5
0
10
20
30
40
50
Femoral Neck BMD (g/cm
2
)
V
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%
)
Fig. 1.Relationship between bonemineral density (BMD) at the femoral neck (g/cm2) and
visceral adipose tissue (VAT) (%) (r2 = 0.444; p-value = 0.018).
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ﬁndings. This relationship may be site-speciﬁc due to the redistribution
of fat and muscle mass following SCI, where leg fat mass was the most
signiﬁcant predictor of leg BMD/BMC (Bauman et al., 2006). The posi-
tive association between adiponectin and BMD at the LS, but not the
FN site found in our study, could be speciﬁc to the site of bone preserva-
tion due to the constant weight bearing in a seated position. LS preser-
vation is evident in the comparable LS BMD of non-SCI controls.
Alternatively, DXA has been found to overestimate the LS BMD in SCI
due to confounding osteophytes or heterotrophic ossiﬁcation
(Bauman et al., 2009), and may mask bone loss following injury.
Following SCI, the gain in adipose tissue concurrent with the loss of
lean and bone tissue results in a redistribution of body composition and
a decreasedmetabolic rate (Buchholz et al., 2003). Since peoplewith SCI
have higher adipose mass, lower circulating adiponectin compared to
non-SCI controls would be expected. Our results found slightly higher
circulating adiponectin in SCI than non-SCI as seen in previous studies
(Edwards et al., 2008; Wang et al., 2005), indicating that the hormonal
mechanism of adiponectin on fat and bone metabolism may differ in
persons with SCI. Alternatively, low resting metabolism after SCI may
protect against hypoadiponectinemia (Ruige et al., 2005). A further
explanation for the unexpected adiponectin ﬁndings is that persons
with SCI produce biologically inactive forms of adiponectin (Sato et al.,
2001; Scherer et al., 1995). The analysis methodology used for assessing
circulating adiponectin measures various forms including both biologi-
cally active and inactive adiponectin, possibly impacting the results
(Wang et al., 2005).
Although nutritional status was not associated with bone outcomes
in the SCI cohort, it is worth noting that to achieve recommended intake
of nutrients, the participants with SCI were highly reliant on supple-
ments; 73% of the participants reported calcium, vitamin D and/or
multivitamin supplementation. Vitamin D was the main nutrient with
suboptimal intakes when accounted from food sources only. Frequent
use of nutrient supplementation has been observed previously in a
cohort of 77 adults with SCI, where 50% of participants consistently
took multivitamin, calcium and vitamin D supplements (Opperman
et al., 2010). Quite remarkably, despite the observed frequency of vita-
min D supplementation, 60% of the participants with SCI demonstrated
suboptimal 25(OH)D status. These ﬁndings align with previous reports
where 32% of persons with SCI (n = 100) had suboptimal 25(OH)D
status (deﬁned as b40 nmol/L) (Bauman et al., 1995). However, when
the cut-off of 70–80 nmol/L is employed, more recent reports of subop-
timal 25(OH)D status were as high as 93% in SCI cohorts (Wong et al.,
2014). Multivitamin use was the only correlate associated with vitamin
D inadequacy, most likely due to the high amounts of calcium and vita-
min D present and other nutrients improving their absorption. Taken
together, data from the present study and other reports indicate that
greater intakes of vitamin D with more reliance on supplementation
as well as clinical monitoring may be necessary for reaching adequate
25(OH)D status in SCI populations.
The lack of a relationship between BMD and skeletal nutrient intake
or 25(OH)D status may be attributable to the wide variability of injury
characteristics in our cohort, or other factors known to inﬂuence low
BMD including: injury duration greater than 10 years, motor complete
injury, female gender, BMI less than 19, medications that increase vita-
min D metabolism and excessive cigarette smoking or alcohol intake
(Hummel et al., 2012). The lack of impact of nutrient intake on bone
status was observed in a study examining the factors contributing to
steroid-induced osteoporosis in children with rheumatic disorders or
nephrosis, possibly due to the overwhelming impact of glucocorticoid
use (Huber et al., 2010; Feber et al., 2012; Rodd et al., 2012b). Signiﬁcant
associations between 25(OH)D status and BMD at the hip have been
observed in non-SCI women over the age of 60 (Dawson-Hughes
et al., 2005), but this relationship has not been previously reported in
SCI. In our SCI cohort, bone loss appeared site speciﬁc at the FN,whereas
bone mass was preserved in the LS. Future research should includeevaluations of BMD at the proximal tibia and distal femur sites, where
the highest incidence of fractures occurs (Craven et al., 2009). The
observation of signiﬁcantly lower FN BMD in our participants with SCI
in comparison to non-SCI was expected since aBMD is known to decline
by 20–32% within the ﬁrst year of injury, particularly in the lower
extremities (Craven et al., 2009).
Limitations to the current study include the cross-sectional observa-
tional design, which does not allow for observations to be made with
regards to the chronology of outcomes or causality of relationships
between different outcomes. Many of our participants were recruited
from the MacWheelers Rehabilitation Centre at McMaster University
and may not be generalizable to all persons with SCI due to their habit-
ual exercise routine. In addition, the small and heterogeneous sample
size did not allow confounding covariates of inadequate 25(OH)D status
and sub-optimal bone status to be controlled.
5. Conclusions
The results of this study found thatmarkers of adipositywere closely
related to BMD at the FN and LS skeletal sites in adults with chronic SCI,
while nutrition and 25(OH)D status showed no association with BMD.
The observed positive correlations between adiposity markers with
BMD suggest that higher hormone levels resulting from greater adipose
tissue, rather than mechanical weight bearing, may activate bone
remodeling in the SCI population. Further understanding of the relation-
ships between adiposity and bone health may help to identify the
effects of the drastic body composition changes during the acute and
chronic phases of SCI. With increasing rates of SCI predicted in the
coming decades (Noonan et al., 2012), research on accurate prevention,
treatment, and rehabilitation of SLOP is necessary to improve the quality
of life of individuals with SCI and reduce healthcare costs.
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